Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Fucoidan inhibits the progression of hepatocellular carcinoma via causing lncRNA Linc00261 overexpression

PROVIDER: PRJNA690771 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR13387007_1.fastq.gz	Fastqsanger.gz
	SRR13387007_2.fastq.gz	Fastqsanger.gz
	SRR13387008_1.fastq.gz	Fastqsanger.gz
	SRR13387008_2.fastq.gz	Fastqsanger.gz
	SRR13387009_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 8

Similar Datasets

Expression data from adult transgenic zebrafish

Project description:Hepatocellular carcinoma is the fourth leading cause of cancer-related deaths worldwide. Many carcinogens induce inflammation and cirrhosis, and eventually develop into liver cancer. Fucoidan is sulfated polysaccharide that is mainly found in brown seaweeds. In this study, we investigated the effects and mechanisms of low molecular weight fucoidan (i.e. oligo-fucoidan) preventing hepatocarcinogenesis using HBx,Src, and HBx,Src,p53-/+ transgenic zebrafish liver cancer model. Using an oligo-fucoidan oral gavage in adult transgenic zebrafish, we then used microarrays to detail the global programme of gene expression after fucoidan treatment and identified distinct classes of up- and down-regulated genes during this process.

2020-04-12 | GSE148501 | GEO

Thyroid hormone inhibits hepatocellular carcinoma progression via induction of differentiation and metabolic reprogramming

Project description:Thyroid hormone inhibits hepatocellular carcinoma progression via induction of differentiation and metabolic reprogramming

| PRJNA542352 | ENA

Transcriptome analysis of BT549 cells overexpressing SNHG15

Project description:LncRNA SNHG15 is an oncogenic lncRNA in a variety of cancers including breast cancer, lung cancer, and hepatocellular carcinoma. To screen genes regulated by SNHG15, we performed RNA-seq with stable SNHG15-overexpression BT549 cells, using BT549-pcIP2 as control.

2023-06-08 | GSE220492 | GEO

Project description:RBM47 Inhibits Hepatocellular Carcinoma Progression as a DNA/RNA Regulator

| PRJNA833052 | ENA

Project description:RBM47 Inhibits Hepatocellular Carcinoma Progression as a DNA/RNA Regulator

| PRJNA833083 | ENA

LncRNA profile of human liver tissues: hepatocellular carcinoma vs. matched noncancerous liver tissue

Project description:LncRNA profiling of hepatocellular carcinoma vs. matched noncancerous liver tissue, aimed to analyze the lncRNA expression proﬁle of hepatocellular carcinoma (HCC) and identify prognosis-related lncRNAs.

2023-06-25 | GSE72170 | GEO

USP1 modulates hepatocellular carcinoma progression via Hippo/TAZ axis

Project description:USP1 modulates hepatocellular carcinoma progression via Hippo/TAZ axis

| PRJNA903373 | ENA

Carfilzomib inhibits the progression of hepatocellular cancer via upregulating GADD45a expression

Project description:Carfilzomib inhibits the progression of hepatocellular cancer via upregulating GADD45a expression

| PRJNA1198859 | ENA

LINC00261 is an epigenetically-regulated tumor suppressor that is essential for activation of the DNA damage response [H522-LINC00261 RNA-seq data set]

Project description:Lung cancer is the leading cause of cancer-related death in the United States. Long non-coding RNAs (lncRNAs) are a class of regulatory molecules whose role in lung carcinogenesis is poorly understood. In this study, we profiled lncRNA expression in lung adenocarcinoma (LUAD) cell lines, compared their expression to that of purified alveolar epithelial type II cells (the purported cell of origin for LUAD), cross-referenced these with lncRNAs altered in primary human tumors, and interrogated for lncRNA whose expression correlated with patient survival. We identified LINC00261, a lncRNA with unknown function in LUAD, adjacent to the pioneering transcription factor FOXA2. Loss of LINC00261 was observed in multiple tumor types, including liver, breast, and gastric cancer. Reintroduction of LINC00261 into human LUAD cell lines inhibited cell migration and slowed proliferation by inducing a G2/M cell cycle arrest while upregulating DNA damage pathway genes and inducing phosphorylation-mediated activation of components of the DNA damage pathway. FOXA2 was able to induce LINC00261 expression, and the entire locus underwent hypermethylation in LUAD, leading to loss of expression. We have thus identified an epigenetically deregulated lncRNA, whose loss of expression in LUAD promotes the malignant phenotype and blocks activation of the DNA damage machinery, predisposing lung cells to cancer development.

2019-03-01 | GSE110182 | GEO

LINC00261 is an epigenetically-regulated tumor suppressor that is essential for activation of the DNA damage response (AEC/LUAD RNA-seq data set)

2019-03-01 | GSE110024 | GEO